|
11-04-2011, 06:40 PM
|
|||
|
|||
Study finds increased cancer risk with bone growth product
Spine surgery patients who got a bone growth stimulating agent as part of a clinical trial were three to five times more likely to develop cancer two to three years after being implanted with the product, according to a new analysis.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Linear Mode
